Consensus statement on preventive and symptomatic care of leukodystrophy patients

behalf of the GLIA Consortium

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations

Abstract

Leukodystrophies are inherited disorders whose primary pathophysiology consists of abnormal deposition or progressive disruption of brain myelin. Leukodystrophy patients manifest many of the same symptoms and medical complications despite the wide spectrum of genetic origins. Although no definitive cures exist, all of these conditions are treatable. This report provides the first expert consensus on the recognition and treatment of medical and psychosocial complications associated with leukodystrophies. We include a discussion of serious and potentially preventable medical complications and propose several preventive care strategies. We also outline the need for future research to prioritize clinical needs and subsequently develop, validate, and optimize specific care strategies.

Original languageEnglish (US)
Pages (from-to)516-526
Number of pages11
JournalMolecular genetics and metabolism
Volume114
Issue number4
DOIs
StatePublished - Apr 1 2015

Keywords

  • Care
  • Consensus
  • Leukodystrophy
  • Outcomes
  • Prevention
  • Therapy

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology

Fingerprint

Dive into the research topics of 'Consensus statement on preventive and symptomatic care of leukodystrophy patients'. Together they form a unique fingerprint.

Cite this